Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

5.13
-0.7200-12.31%
Post-market: 5.280.1500+2.92%16:48 EDT
Volume:41.24K
Turnover:222.94K
Market Cap:2.98M
PE:-0.05
High:5.95
Open:5.61
Low:5.07
Close:5.85
52wk High:80.10
52wk Low:2.98
Shares:581.00K
Float Shares:561.10K
Volume Ratio:0.69
T/O Rate:7.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-178.39%
ROA:-60.68%
PB:0.70
PE(LYR):-0.05

Loading ...

SciSparc Subsidiary NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Trials Analytics Platform

Reuters
·
Jul 29

Scisparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

THOMSON REUTERS
·
Jul 27

Scisparc - in Discussions with Companies in Agentic AI Field

THOMSON REUTERS
·
Jul 27

SciSparc initiates SCI-110 clinical trial in Germany

TIPRANKS
·
Jul 15

Scisparc: Neurothera Labs Announces Initiation of Phase Iib Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

THOMSON REUTERS
·
Jul 15

Scisparc Unit Neurothera Labs Starts Phase Iib Tourette Trial Site at Hannover Medical School

Reuters
·
Jul 15

Neurothera Labs Targets up to C$ 5 Million in Private Placement of Units at C$ 0.135 Each

Reuters
·
Jul 01

SciSparc unit NeuroThera closes purchase of 54% stake in CliniQuantum for CAD 9.46 million in shares

Reuters
·
Jun 04

Scisparc: Subsidiary Neurothera Labs Completed Acquisition of Cliniquantum

THOMSON REUTERS
·
Jun 04

SciSparc director Itschak Shrem sells 462 shares for $4,620

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's

Reuters
·
May 29

Why Is SciSparc Stock Skyrocketing On Thursday?

Benzinga
·
May 29

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
May 28

SciSparc unit NeuroThera wins conditional TSX approval for CliniQuantum acquisition update

Reuters
·
May 28

Scisparc: Subsidiary Neurothera Labs Received Conditional Regulatory Approval for Acquisition of Cliniquantum

THOMSON REUTERS
·
May 28

SciSparc regains Nasdaq equity compliance, avoids delisting for now

Reuters
·
May 11

Scisparc FY25 net loss widens 94% to USD 12.18 million

Reuters
·
Apr 30

Scisparc Director Alon Dayan Files Initial Beneficial Ownership Statement

Reuters
·
Mar 24

SciSparc Ltd. CEO and CFO Oz Adler Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Scisparc Ltd. Director Moshe Revach Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19